vascular diseas - Nursing Case Study
Pathophysiology
• Primary mechanism: Endothelial dysfunction - Damage to the vascular endothelium disrupts its normal function, leading to impaired vasodilation, increased permeability, and a pro-inflammatory state, which can initiate atherosclerosis.
• Secondary mechanism: Lipid accumulation and inflammation - Low-density lipoproteins (LDL) infiltrate the vessel wall, becoming oxidized and triggering an inflammatory response. This leads to the formation of atherosclerotic plaques, which can narrow and stiffen arteries.
• Key complication: Plaque rupture and thrombosis - The fibrous cap of an atherosclerotic plaque can rupture, exposing its contents to the bloodstream, triggering clot formation. This can result in acute vascular events such as heart attack or stroke.
Patient Profile
Demographics:
62-year-old female, retired school teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Metformin, Lisinopril, Simvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing leg pain and swelling
• Key symptoms: Intermittent claudication, cold feet, non-healing ulcer on the right foot, numbness in toes
• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F
Section 1
As the nurse continues the initial assessment, a closer inspection of the patient's right foot reveals a non-healing ulcer with a necrotic center surrounded by inflamed tissue, measuring approximately 3 cm in diameter. The surrounding skin is cool to the touch, and there is diminished sensation in the toes, confirmed by monofilament testing. Palpation of the dorsalis pedis and posterior tibial pulses indicates they are faint and barely palpable, suggesting compromised arterial blood flow to the lower extremities. The patient's intermittent claudication has progressed to pain at rest, raising concern for critical limb ischemia.
The nurse notes that the patient's blood pressure remains elevated at 155/98 mmHg, despite adherence to her antihypertensive regimen. Laboratory tests are ordered, including a complete blood count, basic metabolic panel, and lipid profile. Results reveal a HbA1c of 8.5%, indicating suboptimal glycemic control. Additionally, the lipid profile shows elevated LDL levels at 160 mg/dL and low HDL levels at 35 mg/dL, reinforcing the risk of atherosclerotic disease progression.
These findings suggest that the patient's current management plan may be inadequate in preventing further vascular complications. The clinical team discusses potential adjustments, such as intensifying glycemic control with additional antidiabetic medications, revising the lipid-lowering strategy, and considering the initiation of cilostazol to improve peripheral circulation. The immediate focus is on preventing further deterioration of the vascular condition, particularly the risk of ulcer infection or progression to gangrene, while also addressing the patient's overall cardiovascular risk profile.
Section 2
Change in Patient Status:
Despite the initial efforts to address the patient's condition, her status begins to deteriorate over the following 48 hours. The ulcer on her right foot shows signs of infection, with increased purulent discharge and surrounding erythema, extending beyond the initial borders. The patient reports escalating pain in the foot that is not relieved by elevation or analgesics, and her temperature spikes to 101.3°F, indicating a possible systemic infection. Her blood pressure remains elevated at 160/100 mmHg, and her heart rate has increased to 102 bpm, suggesting a compensatory response to infection and pain.
The clinical team decides to initiate broad-spectrum intravenous antibiotics to combat the suspected infection and prevent further tissue necrosis. Blood cultures are taken to identify the causative organism and tailor antibiotic therapy accordingly. The decision is made to consult a vascular surgeon to evaluate the need for possible revascularization or debridement, given the critical limb ischemia and the risk of gangrene. Additionally, adjustments to her antihypertensive and glycemic management are considered urgent, with the introduction of an ACE inhibitor to better control her blood pressure and the addition of insulin to rapidly improve glycemic control.
This change in status necessitates close monitoring of the patient’s vital signs, pain management, and frequent assessment of the infected area to evaluate the effectiveness of the interventions. The nursing team is tasked with providing education about the importance of offloading pressure from the affected foot, signs of worsening infection to watch for, and the need for strict adherence to the revised treatment plan. The primary goal is to stabilize her condition, prevent further complications, and preserve the viability of her limb.
Section 3
Response to Interventions:
Over the next 24 hours, the nursing team closely monitors the patient’s response to the interventions. The administration of broad-spectrum intravenous antibiotics begins to show a positive effect; her temperature decreases to 99.1°F, indicating a partial control of the systemic infection. However, the erythema around the ulcer extends slightly, suggesting that local infection control remains a challenge. The vascular surgeon performs an initial assessment and notes diminished pulses in the affected foot, with capillary refill time extended to over 5 seconds, confirming critical limb ischemia. The patient continues to report severe pain despite analgesic administration, prompting a reassessment of her pain management regimen.
Laboratory results reveal an elevated white blood cell count of 15,000/µL, supporting the diagnosis of infection. Blood cultures identify methicillin-resistant Staphylococcus aureus (MRSA) as the causative organism, necessitating a switch in antibiotic therapy to vancomycin for targeted treatment. The patient’s blood pressure has improved slightly to 148/92 mmHg following the introduction of the ACE inhibitor, but her blood glucose levels continue to fluctuate, with a current reading of 250 mg/dL despite insulin administration. The need for more rigorous glycemic control is evident to support wound healing and infection management.
The interdisciplinary team convenes to discuss the next steps, focusing on aggressive wound care strategies and the possibility of surgical intervention to restore adequate blood flow to the foot. The nursing staff emphasizes the importance of patient education, particularly regarding the signs of worsening infection and the critical nature of adhering to the updated treatment plan. The primary objective remains to stabilize the patient's condition while preventing further complications, such as the development of gangrene, that could endanger the viability of her limb.
Section 4
New Complications:
Despite initial signs of improvement, the patient's condition takes a concerning turn over the next 48 hours. The erythema around the ulcer continues to spread, now extending to the midfoot, and there is increasing drainage with a foul odor, suggesting the progression of the local infection. The vascular surgeon, upon re-evaluation, notes that the pulses in the affected foot are now barely palpable, and capillary refill time has further increased to 7 seconds. This alarming development points towards worsening critical limb ischemia, raising the risk of tissue necrosis and gangrene.
Further complicating the clinical picture, the patient's renal function begins to decline. Her latest laboratory results reveal elevated creatinine levels at 2.1 mg/dL, up from 1.2 mg/dL two days prior, indicating acute kidney injury likely exacerbated by both the infection and the nephrotoxic potential of the vancomycin. Her blood glucose levels remain erratic, with a recent spike to 320 mg/dL despite adjustments to her insulin regimen. These factors collectively threaten to derail the patient's recovery, necessitating a more aggressive, multifaceted approach.
The interdisciplinary team must now reconvene to address these new complications. The nephrologist is consulted for renal support and potential adjustments to antibiotic therapy. Endocrinology is involved for more precise glycemic control strategies. The possibility of surgical intervention becomes more urgent, with the need to reestablish perfusion to the foot and prevent irreversible damage. Nursing staff remain vigilant, continuously monitoring for signs of systemic deterioration and ensuring that the patient and her family fully comprehend the critical nature of the situation and the importance of adhering to the evolving treatment plan.
Section 5
New Diagnostic Results:
The interdisciplinary team proceeds with further diagnostic evaluations to gain a clearer understanding of the patient's deteriorating condition. An urgent Doppler ultrasound of the affected limb is performed, confirming significant reduction in blood flow, particularly in the dorsalis pedis and posterior tibial arteries. This finding is consistent with the worsening critical limb ischemia observed clinically. Furthermore, the MRI of the foot reveals early signs of osteomyelitis, suggesting the infection has penetrated deeper structures. These results underscore the urgency of surgical intervention to restore adequate perfusion and to address the potential for bone involvement.
Laboratory tests reveal additional complications. The patient's white blood cell count has risen to 16,000/µL, indicating an escalating systemic infection, while her C-reactive protein level is markedly elevated at 150 mg/L, further affirming the inflammatory process. Her renal function continues to decline, with creatinine levels now at 2.5 mg/dL. A renal ultrasound, however, shows no evidence of obstructive uropathy, suggesting that the kidney injury is more likely related to the combined effects of infection and nephrotoxic medications. Meanwhile, her blood glucose remains poorly controlled, with frequent spikes despite increased insulin dosing.
These diagnostic results prompt an immediate reassessment of the treatment plan. The team recognizes the need for more aggressive measures to manage the infection, considering alternative antibiotics that are less nephrotoxic. The potential for surgical intervention, such as angioplasty or bypass surgery, is prioritized to improve blood flow and prevent further tissue damage. Additionally, the endocrinology team intensifies glucose management strategies, considering the use of continuous insulin infusion to achieve more stable control. This comprehensive approach aims to stabilize the patient’s condition and prevent further complications, setting the stage for a critical decision-making juncture in her care journey.